Skip to main content
. 2021 Nov 24;13:705594. doi: 10.3389/fnagi.2021.705594

Figure 4.

Figure 4

Immunostained LPS vesicles in the PVWM of AD and aging control brains. (A) LPS was identified in the vesicles in control PVWM using an antibody against LPS and staining with alkaline phosphatase and Vector® Blue Substrate Kit (A1) or horseradish peroxidase and Vector VIP Substrate Kit (A2). (B) LPS was identified in the vesicles in AD PVWM using an antibody against LPS and staining with alkaline phosphatase and Vector Blue Substrate Kit (B1) or horseradish peroxidase and Vector VIP Substrate Kit (B2). (C) Quantitative analysis showed more LPS+ vesicles in AD (44.8 ± 6.5, n = 12) PVWM compared to control PVWM (20.1 ± 6.7, n = 9, p = 0.0085). Note: LPS, lipopolysaccharide; V, ventricle; PVWM, periventricular white matter; AD, Alzheimer's disease; Bar = 100 μm.